IL17A and colorectal neoplasm: Based on this backdrop, our present study revealed that colorectal tumors respond to FOFOX therapy by stimulation of supporting CAFs in the tumor-microenvironment to provide cues in the form of secreted factors (PN and IL17A) to stimulate WNT3A signals to maintain CICs.